Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Non-cash Items: 2023-2024

Historic Non-cash Items for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $108.2 million.

  • CG Oncology's Non-cash Items rose 21.34% to $190.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $190.7 million, marking a year-over-year increase of 21.34%. This contributed to the annual value of $108.2 million for FY2024, which is 168.44% up from last year.
  • Per CG Oncology's latest filing, its Non-cash Items stood at $108.2 million for FY2024, which was up 168.44% from $40.3 million recorded in FY2023.
  • Over the past 5 years, CG Oncology's Non-cash Items peaked at $108.2 million during FY2024, and registered a low of $40.3 million during FY2023.
  • For the 2-year period, CG Oncology's Non-cash Items averaged around $74.2 million, with its median value being $74.2 million (2023).
  • Data for CG Oncology's Non-cash Items shows a peak YoY soared of 168.44% (in 2024) over the last 5 years.
  • Over the past 2 years, CG Oncology's Non-cash Items (Yearly) stood at $40.3 million in 2023, then skyrocketed by 168.44% to $108.2 million in 2024.